TCL Archive Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products June 3, 2011
TCL Archive GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL July 26, 2013
TCL Archive Illinois Congressman Calls For Full Bypass Budget Appropriation In cancer Prevention – $180 Million February 22, 1991